Showing results (661-670 of 881) with videos related to
Sort By:
Pageof 89
Hepatology (Baltimore, Md.)|April 8, 2014
Antiretroviral therapy, interferon sensitivity, and virologic setpoint in human immunodeficiency virus/hepatitis C virus coinfected patientsAshwin Balagopal, Abraham J Kandathil, Yvonne H Higgins, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 15, 2016
Late Relapse Versus Hepatitis C Virus Reinfection in Patients With Sustained Virologic Response After Sofosbuvir-Based TherapiesChristoph Sarrazin, Vasily Isakov, Evguenia S Svarovskaia, et al.JAMA|July 24, 2012
Relationship of liver disease stage and antiviral therapy with liver-related events and death in adults coinfected with HIV/HCVBerkeley N Limketkai, Shruti H Mehta, Catherine G Sutcliffe, et al.Journal of Viral Hepatitis|February 4, 2016
Public health clinic-based hepatitis C testing and linkage to care in BaltimoreO Falade-Nwulia, S H Mehta, J Lasola, et al.Journal of Pediatric Surgery|January 20, 2015
Early versus delayed surgical correction of malrotation in children with critical congenital heart diseaseJason P Sulkowski, Jennifer N Cooper, Eileen M Duggan, et al.Journal of Pediatric Surgery|January 20, 2015
Does timing of neonatal inguinal hernia repair affect outcomes?Jason P Sulkowski, Jennifer N Cooper, Eileen M Duggan, et al.Journal of Pediatric Surgery|March 29, 2016
High failure rate of nonoperative management of acute appendicitis with an appendicolith in childrenJustin B Mahida, Daniel L Lodwick, Kristine M Nacion, et al.Journal of Viral Hepatitis|July 19, 2017
Directly observed therapy of sofosbuvir/ribavirin +/- peginterferon with minimal monitoring for the treatment of chronic hepatitis C in people with a history of drug use in Chennai, India (C-DOT)S S Solomon, M S Sulkowski, P Amrose, et al.Liver International : Official Journal of the International Association for the Study of the Liver|December 13, 2016
Short-duration treatment for chronic hepatitis C virus with daclatasvir, asunaprevir, beclabuvir and sofosbuvir (FOURward study)Mark S Sulkowski, Steve Flamm, Zeid Kayali, et al.AIDS (London, England)|December 20, 2007
Rapid fibrosis progression among HIV/hepatitis C virus-co-infected adultsMark S Sulkowski, Shruti H Mehta, Michael S Torbenson, et al.Pageof 89